Hims & Hers Health Inc (NYSE:HIMS) has a beta value of 1.86 and has seen 18.45 million shares traded in the last trading session. The company, currently valued at $6.05B, closed the last trade at $27.23 per share which meant it gained $0.28 on the day or 1.04% during that session. The HIMS stock price is -168.01% off its 52-week high price of $72.98 and 58.87% above the 52-week low of $11.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 21.95 million shares traded. The 3-month trading volume is 24.85 million shares.
The consensus among analysts is that Hims & Hers Health Inc (HIMS) is Buy stock at the moment, with a recommendation rating of 2.31. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 5 out of 13 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.22.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Sporting 1.04% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the HIMS stock price touched $27.23 or saw a rise of 8.75%. Year-to-date, Hims & Hers Health Inc shares have moved 12.61%, while the 5-day performance has seen it change 1.57%. Over the past 30 days, the shares of Hims & Hers Health Inc (NYSE:HIMS) have changed -19.63%. Short interest in the company has seen 57.77 million shares shorted with days to cover at 2.53.
Wall Street analysts have a consensus price target for the stock at $26, which means that the shares’ value could drop -4.73% from current levels. The projected low price target is $21.0 while the price target rests at a high of $68.0. In that case, then, we find that the current price level is -149.72% off the targeted high while a plunge would see the stock lose 22.88% from current levels.
Hims & Hers Health Inc (HIMS) estimates and forecasts
The company’s shares have gained 19.43% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 57.61%.
11 analysts offering their estimates for the company have set an average revenue estimate of 536.45M for the current quarter. 11 have an estimated revenue figure of 567.06M for the next ending quarter. Year-ago sales stood 278.17M and 315.65M respectively for this quarter and the next, and analysts expect sales will grow by 92.85% for the current quarter and 57.61% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.22% over the past 5 years. Earnings growth for 2025 is a modest 14.37% while over the next 5 years, the company’s earnings are expected to increase by 32.17%.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next earnings report on 2025-Feb-23 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Insiders own 11.30% of the company shares, while shares held by institutions stand at 79.85% with a share float percentage of 90.03%. Investors are also buoyed by the number of investors in a company, with Hims & Hers Health Inc having a total of 555.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 16.47 million shares worth more than $332.55 million. As of 2024-06-30, VANGUARD GROUP INC held 7.7166% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 14.57 million shares as of 2024-06-30. The firm’s total holdings are worth over $294.25 million and represent 6.7907% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 2.92% shares in the company for having 6.24 shares of worth $170.05 million while later fund manager owns 5.27 shares of worth $143.55 million as of Dec 31, 2024 , which makes it owner of about 2.47% of company’s outstanding stock.
